Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma. (Q46803225)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Johann Guillemot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Marc Klein

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Billy Kwok-Chong Chow

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Laurent Yon

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Youssef Anouar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Maïté Montero-Hadjadje

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Eric Grouzmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Joana Roshmaninho-Salgado

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Valérie Turquier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Céline Duparc

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hervé Lefebvre

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Pierre-François Plouin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mihaela Muresan

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hubert Vaudry

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2003-2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16287097%20AND%20SRC:MED&resulttype=core&format=json

The chromogranins A and B: the first 25 years and future perspectives

9 January 2020

cites work

1 reference

The chromogranin-secretogranin family

21 January 2018

1 reference

Impact of chromogranin A measurement in the work-up of neuroendocrine tumors

21 January 2018

1 reference

Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma

21 January 2018

1 reference

Molecular cloning of frog secretogranin II reveals the occurrence of several highly conserved potential regulatory peptides

21 January 2018

1 reference

Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors.

21 January 2018

1 reference

Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations

21 January 2018

1 reference

Malignant pheochromocytoma: current status and initiatives for future progress

21 January 2018

1 reference

The economic implications of three biochemical screening algorithms for pheochromocytoma

21 January 2018

1 reference

Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.

21 January 2018

1 reference

Biochemical diagnosis of pheochromocytoma: which test is best?

21 January 2018

1 reference

Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results

21 January 2018

1 reference

Phosphorylation and O-glycosylation sites of human chromogranin A (CGA79-439) from urine of patients with carcinoid tumors.

21 January 2018

1 reference

Imaging vs biochemical testing for pheochromocytoma

21 January 2018

1 reference